We have a broad range of products catering to critical care segment in parenterals like cephalosporins, carbapenems and oncology drugs in lyophilized form, infusions and small volume parenterals . These products are manufactured in accordance with highest international standards in facilities certified as EU-GMP, WHO-GMP , ISO 9001, ISO 14001 & ISO18001 and Ukrainian GMP compliant.

The pioneering approach of Venus to product innovation enables us to deliver significant benefits to patients and to healthcare professionals. Our R&D team is rigorously working on future focus therapies which will help in optimizing drug delivery, efficacy and safety. Early diagnosis and improved treatment will significantly reduce the need for expensive surgical operations and long hospital stays , with these medicines.